BioMarin Pharmaceutical Inc. (BMRN) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference TranscriptSeeking Alpha • 09/10/26
BioMarin Pharmaceutical Inc. (BMRN) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha • 09/09/26
BioMarin Announces Positive Results of Phase 3 VOXZOGO® (vosoritide) Study in Hypochondroplasia Published in NEJM EvidencePRNewsWire • 09/09/26
How BioMarin Turned a Competitive Threat Into a Royalty-Bearing AssetZacks Investment Research • 09/03/26
Biomarin, Ascendis Reach Mutually Beneficial Agreement Ending Global Patent DisputesBenzinga • 08/31/26
BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and South KoreaPRNewsWire • 08/31/26
BioMarin to acquire Alesta Therapeutics for $275 million for potential rare bone disease treatmentCNBC • 08/19/26
BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin's PipelinePRNewsWire • 08/18/26
Is BioMarin Pharmaceutical (BMRN) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 08/14/26
Wall Street Analysts See a 28.2% Upside in BioMarin (BMRN): Can the Stock Really Move This High?Zacks Investment Research • 08/12/26
Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-TermZacks Investment Research • 08/12/26
BioMarin Pharmaceutical Inc. (BMRN) Presents at Canaccord Genuity's 46th Annual Growth Conference TranscriptSeeking Alpha • 08/12/26
BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in BostonPRNewsWire • 08/10/26
BMRN Stock Up as Q2 Earnings Beat on Sales Growth, 2026 Outlook RaisedZacks Investment Research • 08/07/26
Compared to Estimates, BioMarin (BMRN) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/06/26
BioMarin Pharmaceutical (BMRN) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/06/26